Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models.

Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F, Geis C, Lancaster E, Titulaer MJ, Rosenfeld MR, Graus F.

Lancet Neurol. 2019 Jul 17. pii: S1474-4422(19)30244-3. doi: 10.1016/S1474-4422(19)30244-3. [Epub ahead of print] Review.

PMID:
31326280
2.

[Autoantibody-associated schizophreniform psychoses: pathophysiology, diagnostics, and treatment].

Tebartz van Elst L, Bechter K, Prüss H, Hasan A, Steiner JH, Leypoldt F, Endres D.

Nervenarzt. 2019 Jul;90(7):745-761. doi: 10.1007/s00115-019-0735-1. German.

PMID:
31197396
3.

Atypical presentation of anti-Ma2-associated encephalitis with choreiform movement.

Lamby N, Leypoldt F, Schulz JB, Tauber SC.

Neurol Neuroimmunol Neuroinflamm. 2019 Apr 1;6(3):e557. doi: 10.1212/NXI.0000000000000557. eCollection 2019 May. No abstract available.

4.

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors.

Hopfner F, Müller SH, Steppat D, Miller J, Schmidt N, Wandinger KP, Leypoldt F, Berg D, Franke A, Lieb W, Tittmann L, Balzer-Geldsetzer M, Baudrexel S, Dodel R, Hilker-Roggendorf R, Kalbe E, Kassubek J, Klockgether T, Liepelt-Scarfone I, Mollenhauer B, Neuser P, Reetz K, Riedel O, Schulte C, Schulz JB, Spottke A, Storch A, Trenkwalder C, Wittchen HU, Witt K, Wüllner U, Deuschl G, Kuhlenbäumer G.

Transl Neurodegener. 2019 Apr 3;8:11. doi: 10.1186/s40035-019-0153-0. eCollection 2019.

5.

[Autoantibody-associated schizophreniform psychoses: clinical symptomatology].

Endres D, Bechter K, Prüss H, Hasan A, Steiner J, Leypoldt F, Tebartz van Elst L.

Nervenarzt. 2019 May;90(5):547-563. doi: 10.1007/s00115-019-0700-z. German.

PMID:
30968197
6.

Linking pre-existing biorepositories for medical research: the PopGen 2.0 Network.

Lieb W, Jacobs G, Wolf A, Richter G, Gaede KI, Schwarz J, Arnold N, Böhm R, Buyx A, Cascorbi I, Franke A, Glinicke C, Held-Feindt J, Junker R, Kalthoff H, Kramer HH, Leypoldt F, Maass N, Maetzler W, May S, Mehdorn HM, Röcken C, Schafmayer C, Schrappe M, Schreiber S, Sebens S, Stephani U, Synowitz M, Weimer J, Zabel P, Nöthlings U, Röder C, Krawczak M.

J Community Genet. 2019 Mar 29. doi: 10.1007/s12687-019-00417-8. [Epub ahead of print]

PMID:
30927239
7.

A case of CLIPPERS syndrome responsive to tocilizumab.

Rempe T, Becktepe JS, Metz I, Brück W, Stürner KH, Deuschl G, Berg D, Baron R, Zeuner R, Leypoldt F.

Neurol Neuroimmunol Neuroinflamm. 2019 Feb 1;6(3):e545. doi: 10.1212/NXI.0000000000000545. eCollection 2019 May. No abstract available.

8.

CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration.

Pawlitzki M, Schreiber S, Bittner D, Kreipe J, Leypoldt F, Rupprecht K, Carare RO, Meuth SG, Vielhaber S, Körtvélyessy P.

Front Neurol. 2018 Dec 14;9:1037. doi: 10.3389/fneur.2018.01037. eCollection 2018.

9.

The spectrum of progressive multifocal leukoencephalopathy: a practical approach.

Bartsch T, Rempe T, Leypoldt F, Riedel C, Jansen O, Berg D, Deuschl G.

Eur J Neurol. 2019 Apr;26(4):566-e41. doi: 10.1111/ene.13906. Epub 2019 Feb 8. Review.

PMID:
30629326
10.

Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson's Disease.

Yilmaz R, Strafella AP, Bernard A, Schulte C, van den Heuvel L, Schneiderhan-Marra N, Knorpp T, Joos TO, Leypoldt F, Geritz J, Hansen C, Heinzel S, Apel A, Gasser T, Lang AE, Berg D, Maetzler W, Marras C.

Front Neurol. 2018 Dec 21;9:1123. doi: 10.3389/fneur.2018.01123. eCollection 2018.

11.

Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment.

Schubert J, Brämer D, Huttner HB, Gerner ST, Fuhrer H, Melzer N, Dik A, Prüss H, Ly LT, Fuchs K, Leypoldt F, Nissen G, Schirotzek I, Dohmen C, Bösel J, Lewerenz J, Thaler F, Kraft A, Juranek A, Ringelstein M, Sühs KW, Urbanek C, Scherag A, Geis C, Witte OW, Günther A; GENERATE and IGNITE network.

Neurol Neuroimmunol Neuroinflamm. 2018 Oct 30;6(1):e514. doi: 10.1212/NXI.0000000000000514. eCollection 2019 Jan.

12.

Admission diagnoses of patients later diagnosed with autoimmune encephalitis.

Baumgartner A, Rauer S, Hottenrott T, Leypoldt F, Ufer F, Hegen H, Prüss H, Lewerenz J, Deisenhammer F, Stich O.

J Neurol. 2019 Jan;266(1):124-132. doi: 10.1007/s00415-018-9105-3. Epub 2018 Nov 12.

PMID:
30421340
13.

The prevalence of neural antibodies in temporal lobe epilepsy and the clinical characteristics of seropositive patients.

Elisak M, Krysl D, Hanzalova J, Volna K, Bien CG, Leypoldt F, Marusic P.

Seizure. 2018 Dec;63:1-6. doi: 10.1016/j.seizure.2018.09.009. Epub 2018 Sep 17.

PMID:
30391660
14.

Autoantibody-Mediated Encephalitis.

Wandinger KP, Leypoldt F, Junker R.

Dtsch Arztebl Int. 2018 Nov 5;115(40):666-673. doi: 10.3238/arztebl.2018.0666.

15.

Sex differences in autoimmune disorders of the central nervous system.

Gold SM, Willing A, Leypoldt F, Paul F, Friese MA.

Semin Immunopathol. 2019 Mar;41(2):177-188. doi: 10.1007/s00281-018-0723-8. Epub 2018 Oct 25.

PMID:
30361800
16.

Biomarkers of Neurodegeneration in Autoimmune-Mediated Encephalitis.

Körtvelyessy P, Prüss H, Thurner L, Maetzler W, Vittore-Welliong D, Schultze-Amberger J, Heinze HJ, Reinhold D, Leypoldt F, Schreiber S, Bittner D.

Front Neurol. 2018 Sep 19;9:668. doi: 10.3389/fneur.2018.00668. eCollection 2018.

17.

A Klinefelter patient with an additional mitochondrial mutation: Implications for genotype-driven treatment and mitochondrial mutational load in different tissues and family members.

Dulovic M, Schäffer E, Leypoldt F, Balck A, Schaake S, Hinrichs F, Kirchner H, Brüggemann N, Berg D, Lohmann K.

Parkinsonism Relat Disord. 2018 Sep;54:116-118. doi: 10.1016/j.parkreldis.2018.04.001. Epub 2018 Apr 3. No abstract available.

PMID:
29650490
18.

Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis.

Mueller SH, Färber A, Prüss H, Melzer N, Golombeck KS, Kümpfel T, Thaler F, Elisak M, Lewerenz J, Kaufmann M, Sühs KW, Ringelstein M, Kellinghaus C, Bien CG, Kraft A, Zettl UK, Ehrlich S, Handreka R, Rostásy K, Then Bergh F, Faiss JH, Lieb W, Franke A, Kuhlenbäumer G, Wandinger KP, Leypoldt F; German Network for Research on Autoimmune Encephalitis (GENERATE).

Ann Neurol. 2018 Apr;83(4):863-869. doi: 10.1002/ana.25216.

PMID:
29572931
19.

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature.

Jarius S, Ruprecht K, Stellmann JP, Huss A, Ayzenberg I, Willing A, Trebst C, Pawlitzki M, Abdelhak A, Grüter T, Leypoldt F, Haas J, Kleiter I, Tumani H, Fechner K, Reindl M, Paul F, Wildemann B.

J Neuroinflammation. 2018 Mar 19;15(1):88. doi: 10.1186/s12974-018-1108-6. Review.

20.

NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody.

Malviya M, Barman S, Golombeck KS, Planagumà J, Mannara F, Strutz-Seebohm N, Wrzos C, Demir F, Baksmeier C, Steckel J, Falk KK, Gross CC, Kovac S, Bönte K, Johnen A, Wandinger KP, Martín-García E, Becker AJ, Elger CE, Klöcker N, Wiendl H, Meuth SG, Hartung HP, Seebohm G, Leypoldt F, Maldonado R, Stadelmann C, Dalmau J, Melzer N, Goebels N.

Ann Clin Transl Neurol. 2017 Oct 3;4(11):768-783. doi: 10.1002/acn3.444. eCollection 2017 Nov.

21.

Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.

Hennes EM, Baumann M, Schanda K, Anlar B, Bajer-Kornek B, Blaschek A, Brantner-Inthaler S, Diepold K, Eisenkölbl A, Gotwald T, Kuchukhidze G, Gruber-Sedlmayr U, Häusler M, Höftberger R, Karenfort M, Klein A, Koch J, Kraus V, Lechner C, Leiz S, Leypoldt F, Mader S, Marquard K, Poggenburg I, Pohl D, Pritsch M, Raucherzauner M, Schimmel M, Thiels C, Tibussek D, Vieker S, Zeches C, Berger T, Reindl M, Rostásy K; BIOMARKER Study Group.

Neurology. 2017 Aug 29;89(9):900-908. doi: 10.1212/WNL.0000000000004312. Epub 2017 Aug 2.

22.

Mechanisms of Autoantibody-Induced Pathology.

Ludwig RJ, Vanhoorelbeke K, Leypoldt F, Kaya Z, Bieber K, McLachlan SM, Komorowski L, Luo J, Cabral-Marques O, Hammers CM, Lindstrom JM, Lamprecht P, Fischer A, Riemekasten G, Tersteeg C, Sondermann P, Rapoport B, Wandinger KP, Probst C, El Beidaq A, Schmidt E, Verkman A, Manz RA, Nimmerjahn F.

Front Immunol. 2017 May 31;8:603. doi: 10.3389/fimmu.2017.00603. eCollection 2017. Review.

23.

ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports.

Körtvélyessy P, Breu M, Pawlitzki M, Metz I, Heinze HJ, Matzke M, Mawrin C, Rommer P, Kovacs GG, Mitter C, Reindl M, Brück W, Wandinger KP, Lassmann H, Höftberger R, Leypoldt F.

Neurol Neuroimmunol Neuroinflamm. 2017 Mar 14;4(3):e335. doi: 10.1212/NXI.0000000000000335. eCollection 2017 May. No abstract available.

24.

Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma.

Koch M, Furtado JD, Falk K, Leypoldt F, Mukamal KJ, Jensen MK.

Alzheimers Dement (Amst). 2017 Feb 24;6:182-187. doi: 10.1016/j.dadm.2017.01.007. eCollection 2017.

25.

Serum neuronal cell-surface antibodies in first-episode psychosis.

Leypoldt F, de Witte L, Lancaster E, Titulaer MJ.

Lancet Psychiatry. 2017 Mar;4(3):186-187. doi: 10.1016/S2215-0366(17)30043-3. No abstract available.

PMID:
28236946
26.

[Autoantibody-associated autoimmune encephalitis and cerebellitis : Clinical presentation, diagnostic work-up and treatment].

Lewerenz J, Jarius S, Wildemann B, Wandinger KP, Leypoldt F.

Nervenarzt. 2016 Dec;87(12):1293-1299. Review. German.

PMID:
27847964
27.

Orthostatic myoclonus associated with Caspr2 antibodies.

van Gerpen JA, Ahlskog JE, Chen R, Fung VS, Hallett M, Gövert F, Deuschl G, Leypoldt F.

Neurology. 2016 Sep 13;87(11):1187-8. doi: 10.1212/WNL.0000000000003140. No abstract available.

PMID:
27621382
28.

The clinical spectrum of Caspr2 antibody-associated disease.

van Sonderen A, Ariño H, Petit-Pedrol M, Leypoldt F, Körtvélyessy P, Wandinger KP, Lancaster E, Wirtz PW, Schreurs MW, Sillevis Smitt PA, Graus F, Dalmau J, Titulaer MJ.

Neurology. 2016 Aug 2;87(5):521-8. doi: 10.1212/WNL.0000000000002917. Epub 2016 Jul 1.

29.

Orthostatic myoclonus associated with Caspr2 antibodies.

Gövert F, Witt K, Erro R, Hellriegel H, Paschen S, Martinez-Hernandez E, Wandinger KP, Deuschl G, Dalmau J, Leypoldt F.

Neurology. 2016 Apr 5;86(14):1353-1355. doi: 10.1212/WNL.0000000000002547. Epub 2016 Mar 4. No abstract available.

30.

A clinical approach to diagnosis of autoimmune encephalitis.

Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J.

Lancet Neurol. 2016 Apr;15(4):391-404. doi: 10.1016/S1474-4422(15)00401-9. Epub 2016 Feb 20. Review.

31.

Quantitative T2* mapping reveals early temporo-spatial dynamics in an ischemic stroke model.

Gersing AS, Faymonville AM, Schwaiger BJ, Leypoldt F, Siemonsen S, Zimmer C, Magnus T, Fiehler J.

J Neurosci Methods. 2016 Feb 1;259:83-89. doi: 10.1016/j.jneumeth.2015.11.018. Epub 2015 Nov 29.

PMID:
26645798
32.

Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease.

Lechner C, Baumann M, Hennes EM, Schanda K, Marquard K, Karenfort M, Leiz S, Pohl D, Venkateswaran S, Pritsch M, Koch J, Schimmel M, Häusler M, Klein A, Blaschek A, Thiels C, Lücke T, Gruber-Sedlmayr U, Kornek B, Hahn A, Leypoldt F, Sandrieser T, Gallwitz H, Stoffels J, Korenke C, Reindl M, Rostásy K.

J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):897-905. doi: 10.1136/jnnp-2015-311743. Epub 2015 Dec 8.

PMID:
26645082
33.

Gardening gone awry: Aberrant spine pruning disrupts long-range networks.

Leypoldt F, Münchau A.

Mov Disord. 2015 Oct;30(12):1621. doi: 10.1002/mds.26380. Epub 2015 Aug 21. Review. No abstract available.

PMID:
26293311
34.

Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate.

Bartsch T, Rempe T, Wrede A, Leypoldt F, Brück W, Adams O, Rohr A, Jansen O, Wüthrich C, Deuschl G, Koralnik IJ.

Ann Neurol. 2015 Oct;78(4):501-14. doi: 10.1002/ana.24471. Epub 2015 Jul 31. Review.

35.

Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients.

Höftberger R, van Sonderen A, Leypoldt F, Houghton D, Geschwind M, Gelfand J, Paredes M, Sabater L, Saiz A, Titulaer MJ, Graus F, Dalmau J.

Neurology. 2015 Jun 16;84(24):2403-12. doi: 10.1212/WNL.0000000000001682. Epub 2015 May 15.

36.

Structural Hippocampal Damage Following Anti-N-Methyl-D-Aspartate Receptor Encephalitis.

Finke C, Kopp UA, Pajkert A, Behrens JR, Leypoldt F, Wuerfel JT, Ploner CJ, Prüss H, Paul F.

Biol Psychiatry. 2016 May 1;79(9):727-734. doi: 10.1016/j.biopsych.2015.02.024. Epub 2015 Feb 26.

PMID:
25866294
37.

Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.

Leypoldt F, Höftberger R, Titulaer MJ, Armangue T, Gresa-Arribas N, Jahn H, Rostásy K, Schlumberger W, Meyer T, Wandinger KP, Rosenfeld MR, Graus F, Dalmau J.

JAMA Neurol. 2015 Feb;72(2):180-6. doi: 10.1001/jamaneurol.2014.2956.

38.

Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice.

Planagumà J, Leypoldt F, Mannara F, Gutiérrez-Cuesta J, Martín-García E, Aguilar E, Titulaer MJ, Petit-Pedrol M, Jain A, Balice-Gordon R, Lakadamyali M, Graus F, Maldonado R, Dalmau J.

Brain. 2015 Jan;138(Pt 1):94-109. doi: 10.1093/brain/awu310. Epub 2014 Nov 11.

39.

Autoimmune encephalopathies.

Leypoldt F, Armangue T, Dalmau J.

Ann N Y Acad Sci. 2015 Mar;1338:94-114. doi: 10.1111/nyas.12553. Epub 2014 Oct 14. Review.

40.

Immunoglobulin G antibodies to the N-Methyl-D-aspartate receptor are distinct from immunoglobulin A and immunoglobulin M responses.

Lancaster E, Leypoldt F, Titulaer MJ, Honnorat J, Waters PJ, Reindl M, Höftberger R.

Ann Neurol. 2015 Jan;77(1):183. doi: 10.1002/ana.24233. Epub 2014 Dec 4. No abstract available.

41.

Author response.

Leypoldt F, Dalmau J.

Neurology. 2014 Jun 3;82(22):2041. No abstract available.

PMID:
25013887
42.

Autoimmune encephalitis as differential diagnosis of infectious encephalitis.

Armangue T, Leypoldt F, Dalmau J.

Curr Opin Neurol. 2014 Jun;27(3):361-8. doi: 10.1097/WCO.0000000000000087. Review.

43.

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

Titulaer MJ, Höftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, Benson LA, Shu H, Irioka T, Hirano M, Singh G, Cobo Calvo A, Kaida K, Morales PS, Wirtz PW, Yamamoto T, Reindl M, Rosenfeld MR, Graus F, Saiz A, Dalmau J.

Ann Neurol. 2014 Mar;75(3):411-28.

44.

Antibodies to N-methyl-D-aspartate and other synaptic receptors in choreoathetosis and relapsing symptoms post-herpes virus encephalitis.

Titulaer MJ, Leypoldt F, Dalmau J.

Mov Disord. 2014 Jan;29(1):3-6. doi: 10.1002/mds.25716. Epub 2013 Nov 4. No abstract available.

45.

Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.

Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, Gleichman AJ, Balice-Gordon R, Rosenfeld MR, Lynch D, Graus F, Dalmau J.

Lancet Neurol. 2014 Feb;13(2):167-77. doi: 10.1016/S1474-4422(13)70282-5. Epub 2013 Dec 18. Erratum in: Lancet Neurol. 2014 Feb;13(2):135.

46.

Herpes simplex virus encephalitis is a trigger of brain autoimmunity.

Armangue T, Leypoldt F, Málaga I, Raspall-Chaure M, Marti I, Nichter C, Pugh J, Vicente-Rasoamalala M, Lafuente-Hidalgo M, Macaya A, Ke M, Titulaer MJ, Höftberger R, Sheriff H, Glaser C, Dalmau J.

Ann Neurol. 2014 Feb;75(2):317-23. doi: 10.1002/ana.24083. Epub 2014 Feb 25.

47.

Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report.

Leypoldt F, Titulaer MJ, Aguilar E, Walther J, Bönstrup M, Havemeister S, Teegen B, Lütgehetmann M, Rosenkranz M, Magnus T, Dalmau J.

Neurology. 2013 Oct 29;81(18):1637-9. doi: 10.1212/WNL.0b013e3182a9f531. Epub 2013 Oct 2. No abstract available.

48.

Immune activation in amyloid-β-related angiitis correlates with decreased parenchymal amyloid-β plaque load.

Bogner S, Bernreuther C, Matschke J, Barrera-Ocampo A, Sepulveda-Falla D, Leypoldt F, Magnus T, Haag F, Bergmann M, Brück W, Vogelgesang S, Glatzel M.

Neurodegener Dis. 2014;13(1):38-44. doi: 10.1159/000352020. Epub 2013 Sep 6.

PMID:
24021982
49.

[Autoimmune encephalitis].

Leypoldt F.

Fortschr Neurol Psychiatr. 2013 Sep;81(9):523-37; quiz 538. doi: 10.1055/s-0033-1350145. Epub 2013 Aug 28. Review. German. No abstract available.

PMID:
23986460
50.

Paraneoplastic neurological syndromes.

Leypoldt F, Wandinger KP.

Clin Exp Immunol. 2014 Mar;175(3):336-48. doi: 10.1111/cei.12185. Review.

Supplemental Content

Loading ...
Support Center